nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—PTGS2—thyroid cancer	0.297	1	CbGaD
Celecoxib—ORM1—Vandetanib—thyroid cancer	0.13	0.37	CbGbCtD
Celecoxib—ABCC4—Sorafenib—thyroid cancer	0.0892	0.253	CbGbCtD
Celecoxib—ALB—Vandetanib—thyroid cancer	0.0548	0.156	CbGbCtD
Celecoxib—CYP2C9—Sorafenib—thyroid cancer	0.0178	0.0506	CbGbCtD
Celecoxib—CYP3A4—Vandetanib—thyroid cancer	0.0172	0.0488	CbGbCtD
Celecoxib—CYP2D6—Sorafenib—thyroid cancer	0.0163	0.0463	CbGbCtD
Celecoxib—CYP3A4—Sorafenib—thyroid cancer	0.0104	0.0294	CbGbCtD
Celecoxib—CYP2D6—Doxorubicin—thyroid cancer	0.00989	0.0281	CbGbCtD
Celecoxib—CYP3A4—Doxorubicin—thyroid cancer	0.00629	0.0178	CbGbCtD
Celecoxib—MAPK14—neck—thyroid cancer	0.00261	0.0842	CbGeAlD
Celecoxib—PDPK1—thyroid gland—thyroid cancer	0.00233	0.0749	CbGeAlD
Celecoxib—CA6—saliva-secreting gland—thyroid cancer	0.00231	0.0743	CbGeAlD
Celecoxib—PDPK1—head—thyroid cancer	0.00206	0.0665	CbGeAlD
Celecoxib—PDPK1—lymph node—thyroid cancer	0.00145	0.0465	CbGeAlD
Celecoxib—Etoricoxib—PTGS2—thyroid cancer	0.00132	1	CrCbGaD
Celecoxib—CA6—head—thyroid cancer	0.00125	0.0402	CbGeAlD
Celecoxib—MAPK14—thyroid gland—thyroid cancer	0.00124	0.0401	CbGeAlD
Celecoxib—CA4—neck—thyroid cancer	0.00123	0.0395	CbGeAlD
Celecoxib—CA12—trachea—thyroid cancer	0.00119	0.0384	CbGeAlD
Celecoxib—MAPK14—head—thyroid cancer	0.0011	0.0356	CbGeAlD
Celecoxib—CA2—neck—thyroid cancer	0.00102	0.0328	CbGeAlD
Celecoxib—CA4—saliva-secreting gland—thyroid cancer	0.000958	0.0308	CbGeAlD
Celecoxib—CA5B—thyroid gland—thyroid cancer	0.000847	0.0273	CbGeAlD
Celecoxib—CA12—head—thyroid cancer	0.000838	0.027	CbGeAlD
Celecoxib—CA2—saliva-secreting gland—thyroid cancer	0.000794	0.0256	CbGeAlD
Celecoxib—MAPK14—lymph node—thyroid cancer	0.000773	0.0249	CbGeAlD
Celecoxib—CA5B—head—thyroid cancer	0.000751	0.0242	CbGeAlD
Celecoxib—CA4—trachea—thyroid cancer	0.000739	0.0238	CbGeAlD
Celecoxib—ABCC4—thyroid gland—thyroid cancer	0.000636	0.0205	CbGeAlD
Celecoxib—CA2—trachea—thyroid cancer	0.000613	0.0197	CbGeAlD
Celecoxib—CA4—thyroid gland—thyroid cancer	0.000585	0.0188	CbGeAlD
Celecoxib—ABCC4—head—thyroid cancer	0.000564	0.0182	CbGeAlD
Celecoxib—CA5B—lymph node—thyroid cancer	0.000526	0.0169	CbGeAlD
Celecoxib—CA4—head—thyroid cancer	0.000519	0.0167	CbGeAlD
Celecoxib—CA2—thyroid gland—thyroid cancer	0.000485	0.0156	CbGeAlD
Celecoxib—ORM1—lymph node—thyroid cancer	0.000465	0.015	CbGeAlD
Celecoxib—PTGS2—trachea—thyroid cancer	0.000452	0.0146	CbGeAlD
Celecoxib—CA2—head—thyroid cancer	0.00043	0.0138	CbGeAlD
Celecoxib—ALB—lymph node—thyroid cancer	0.000408	0.0131	CbGeAlD
Celecoxib—ABCC4—lymph node—thyroid cancer	0.000395	0.0127	CbGeAlD
Celecoxib—CA4—lymph node—thyroid cancer	0.000363	0.0117	CbGeAlD
Celecoxib—PTGS2—head—thyroid cancer	0.000318	0.0102	CbGeAlD
Celecoxib—CA2—lymph node—thyroid cancer	0.000301	0.0097	CbGeAlD
Celecoxib—CYP2D6—head—thyroid cancer	0.000273	0.00879	CbGeAlD
Celecoxib—PTGS2—lymph node—thyroid cancer	0.000222	0.00716	CbGeAlD
Celecoxib—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.000163	0.000857	CcSEcCtD
Celecoxib—Asthenia—Sorafenib—thyroid cancer	0.000162	0.000856	CcSEcCtD
Celecoxib—Hypoglycaemia—Doxorubicin—thyroid cancer	0.000161	0.00085	CcSEcCtD
Celecoxib—Cardiac failure—Doxorubicin—thyroid cancer	0.000161	0.00085	CcSEcCtD
Celecoxib—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.000161	0.000847	CcSEcCtD
Celecoxib—Pruritus—Sorafenib—thyroid cancer	0.00016	0.000844	CcSEcCtD
Celecoxib—Ataxia—Epirubicin—thyroid cancer	0.00016	0.000843	CcSEcCtD
Celecoxib—Blood creatinine increased—Epirubicin—thyroid cancer	0.000159	0.00084	CcSEcCtD
Celecoxib—Hyponatraemia—Doxorubicin—thyroid cancer	0.000158	0.000833	CcSEcCtD
Celecoxib—Osteoarthritis—Doxorubicin—thyroid cancer	0.000157	0.00083	CcSEcCtD
Celecoxib—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.000157	0.00083	CcSEcCtD
Celecoxib—Liver function test abnormal—Epirubicin—thyroid cancer	0.000157	0.000828	CcSEcCtD
Celecoxib—Dry skin—Epirubicin—thyroid cancer	0.000156	0.000822	CcSEcCtD
Celecoxib—Abdominal pain upper—Epirubicin—thyroid cancer	0.000155	0.000819	CcSEcCtD
Celecoxib—Migraine—Doxorubicin—thyroid cancer	0.000155	0.000817	CcSEcCtD
Celecoxib—Hypokalaemia—Epirubicin—thyroid cancer	0.000155	0.000816	CcSEcCtD
Celecoxib—Diarrhoea—Sorafenib—thyroid cancer	0.000155	0.000816	CcSEcCtD
Celecoxib—Breast disorder—Epirubicin—thyroid cancer	0.000154	0.00081	CcSEcCtD
Celecoxib—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.000153	0.000807	CcSEcCtD
Celecoxib—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.000153	0.000807	CcSEcCtD
Celecoxib—Nasopharyngitis—Epirubicin—thyroid cancer	0.000152	0.000802	CcSEcCtD
Celecoxib—Face oedema—Doxorubicin—thyroid cancer	0.000152	0.000801	CcSEcCtD
Celecoxib—Gastritis—Epirubicin—thyroid cancer	0.00015	0.000794	CcSEcCtD
Celecoxib—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.00015	0.000791	CcSEcCtD
Celecoxib—Dizziness—Sorafenib—thyroid cancer	0.00015	0.000789	CcSEcCtD
Celecoxib—Ataxia—Doxorubicin—thyroid cancer	0.000148	0.00078	CcSEcCtD
Celecoxib—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000147	0.000777	CcSEcCtD
Celecoxib—Dysphagia—Epirubicin—thyroid cancer	0.000147	0.000775	CcSEcCtD
Celecoxib—Eosinophilia—Epirubicin—thyroid cancer	0.000146	0.000767	CcSEcCtD
Celecoxib—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000145	0.000766	CcSEcCtD
Celecoxib—Dry skin—Doxorubicin—thyroid cancer	0.000144	0.000761	CcSEcCtD
Celecoxib—Pancreatitis—Epirubicin—thyroid cancer	0.000144	0.00076	CcSEcCtD
Celecoxib—Vomiting—Sorafenib—thyroid cancer	0.000144	0.000758	CcSEcCtD
Celecoxib—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000144	0.000758	CcSEcCtD
Celecoxib—Hypokalaemia—Doxorubicin—thyroid cancer	0.000143	0.000755	CcSEcCtD
Celecoxib—Angina pectoris—Epirubicin—thyroid cancer	0.000143	0.000755	CcSEcCtD
Celecoxib—Rash—Sorafenib—thyroid cancer	0.000143	0.000752	CcSEcCtD
Celecoxib—Dermatitis—Sorafenib—thyroid cancer	0.000142	0.000751	CcSEcCtD
Celecoxib—Breast disorder—Doxorubicin—thyroid cancer	0.000142	0.00075	CcSEcCtD
Celecoxib—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000142	0.000747	CcSEcCtD
Celecoxib—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000142	0.000747	CcSEcCtD
Celecoxib—Headache—Sorafenib—thyroid cancer	0.000142	0.000747	CcSEcCtD
Celecoxib—Bronchitis—Epirubicin—thyroid cancer	0.000141	0.000745	CcSEcCtD
Celecoxib—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000141	0.000742	CcSEcCtD
Celecoxib—Pancytopenia—Epirubicin—thyroid cancer	0.00014	0.000736	CcSEcCtD
Celecoxib—Gastritis—Doxorubicin—thyroid cancer	0.000139	0.000734	CcSEcCtD
Celecoxib—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000139	0.000732	CcSEcCtD
Celecoxib—Dysuria—Epirubicin—thyroid cancer	0.000137	0.000725	CcSEcCtD
Celecoxib—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000137	0.00072	CcSEcCtD
Celecoxib—Dysphagia—Doxorubicin—thyroid cancer	0.000136	0.000717	CcSEcCtD
Celecoxib—Pollakiuria—Epirubicin—thyroid cancer	0.000136	0.000716	CcSEcCtD
Celecoxib—Eosinophilia—Doxorubicin—thyroid cancer	0.000135	0.00071	CcSEcCtD
Celecoxib—Nausea—Sorafenib—thyroid cancer	0.000134	0.000708	CcSEcCtD
Celecoxib—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000134	0.000707	CcSEcCtD
Celecoxib—Weight increased—Epirubicin—thyroid cancer	0.000134	0.000705	CcSEcCtD
Celecoxib—Pancreatitis—Doxorubicin—thyroid cancer	0.000133	0.000703	CcSEcCtD
Celecoxib—Hyperglycaemia—Epirubicin—thyroid cancer	0.000133	0.000699	CcSEcCtD
Celecoxib—Angina pectoris—Doxorubicin—thyroid cancer	0.000132	0.000699	CcSEcCtD
Celecoxib—Pneumonia—Epirubicin—thyroid cancer	0.000132	0.000695	CcSEcCtD
Celecoxib—Infestation NOS—Epirubicin—thyroid cancer	0.000131	0.000691	CcSEcCtD
Celecoxib—Infestation—Epirubicin—thyroid cancer	0.000131	0.000691	CcSEcCtD
Celecoxib—Bronchitis—Doxorubicin—thyroid cancer	0.000131	0.00069	CcSEcCtD
Celecoxib—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.00013	0.000685	CcSEcCtD
Celecoxib—Pancytopenia—Doxorubicin—thyroid cancer	0.000129	0.000681	CcSEcCtD
Celecoxib—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000128	0.000677	CcSEcCtD
Celecoxib—Jaundice—Epirubicin—thyroid cancer	0.000128	0.000674	CcSEcCtD
Celecoxib—Stomatitis—Epirubicin—thyroid cancer	0.000128	0.000674	CcSEcCtD
Celecoxib—Conjunctivitis—Epirubicin—thyroid cancer	0.000127	0.000672	CcSEcCtD
Celecoxib—Urinary tract infection—Epirubicin—thyroid cancer	0.000127	0.000672	CcSEcCtD
Celecoxib—Dysuria—Doxorubicin—thyroid cancer	0.000127	0.000671	CcSEcCtD
Celecoxib—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000126	0.000666	CcSEcCtD
Celecoxib—Pollakiuria—Doxorubicin—thyroid cancer	0.000126	0.000662	CcSEcCtD
Celecoxib—Haematuria—Epirubicin—thyroid cancer	0.000125	0.000659	CcSEcCtD
Celecoxib—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000124	0.000655	CcSEcCtD
Celecoxib—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000124	0.000654	CcSEcCtD
Celecoxib—Weight increased—Doxorubicin—thyroid cancer	0.000124	0.000653	CcSEcCtD
Celecoxib—Epistaxis—Epirubicin—thyroid cancer	0.000124	0.000652	CcSEcCtD
Celecoxib—Sinusitis—Epirubicin—thyroid cancer	0.000123	0.000648	CcSEcCtD
Celecoxib—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000123	0.000647	CcSEcCtD
Celecoxib—Agranulocytosis—Epirubicin—thyroid cancer	0.000122	0.000645	CcSEcCtD
Celecoxib—Pneumonia—Doxorubicin—thyroid cancer	0.000122	0.000643	CcSEcCtD
Celecoxib—Infestation NOS—Doxorubicin—thyroid cancer	0.000121	0.000639	CcSEcCtD
Celecoxib—Infestation—Doxorubicin—thyroid cancer	0.000121	0.000639	CcSEcCtD
Celecoxib—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.00012	0.000634	CcSEcCtD
Celecoxib—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000119	0.000627	CcSEcCtD
Celecoxib—Haemoglobin—Epirubicin—thyroid cancer	0.000118	0.000623	CcSEcCtD
Celecoxib—Jaundice—Doxorubicin—thyroid cancer	0.000118	0.000623	CcSEcCtD
Celecoxib—Stomatitis—Doxorubicin—thyroid cancer	0.000118	0.000623	CcSEcCtD
Celecoxib—Rhinitis—Epirubicin—thyroid cancer	0.000118	0.000622	CcSEcCtD
Celecoxib—Conjunctivitis—Doxorubicin—thyroid cancer	0.000118	0.000622	CcSEcCtD
Celecoxib—Urinary tract infection—Doxorubicin—thyroid cancer	0.000118	0.000622	CcSEcCtD
Celecoxib—Haemorrhage—Epirubicin—thyroid cancer	0.000118	0.00062	CcSEcCtD
Celecoxib—Hepatitis—Epirubicin—thyroid cancer	0.000118	0.00062	CcSEcCtD
Celecoxib—Hypoaesthesia—Epirubicin—thyroid cancer	0.000117	0.000617	CcSEcCtD
Celecoxib—Pharyngitis—Epirubicin—thyroid cancer	0.000117	0.000616	CcSEcCtD
Celecoxib—Urinary tract disorder—Epirubicin—thyroid cancer	0.000116	0.000613	CcSEcCtD
Celecoxib—Oedema peripheral—Epirubicin—thyroid cancer	0.000116	0.000611	CcSEcCtD
Celecoxib—Haematuria—Doxorubicin—thyroid cancer	0.000116	0.00061	CcSEcCtD
Celecoxib—Connective tissue disorder—Epirubicin—thyroid cancer	0.000116	0.00061	CcSEcCtD
Celecoxib—Urethral disorder—Epirubicin—thyroid cancer	0.000115	0.000608	CcSEcCtD
Celecoxib—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000115	0.000605	CcSEcCtD
Celecoxib—Epistaxis—Doxorubicin—thyroid cancer	0.000114	0.000603	CcSEcCtD
Celecoxib—Sinusitis—Doxorubicin—thyroid cancer	0.000114	0.0006	CcSEcCtD
Celecoxib—Agranulocytosis—Doxorubicin—thyroid cancer	0.000113	0.000597	CcSEcCtD
Celecoxib—Erythema multiforme—Epirubicin—thyroid cancer	0.000111	0.000587	CcSEcCtD
Celecoxib—Eye disorder—Epirubicin—thyroid cancer	0.00011	0.00058	CcSEcCtD
Celecoxib—Tinnitus—Epirubicin—thyroid cancer	0.00011	0.000578	CcSEcCtD
Celecoxib—Haemoglobin—Doxorubicin—thyroid cancer	0.000109	0.000577	CcSEcCtD
Celecoxib—Flushing—Epirubicin—thyroid cancer	0.000109	0.000576	CcSEcCtD
Celecoxib—Cardiac disorder—Epirubicin—thyroid cancer	0.000109	0.000576	CcSEcCtD
Celecoxib—Rhinitis—Doxorubicin—thyroid cancer	0.000109	0.000575	CcSEcCtD
Celecoxib—Hepatitis—Doxorubicin—thyroid cancer	0.000109	0.000574	CcSEcCtD
Celecoxib—Haemorrhage—Doxorubicin—thyroid cancer	0.000109	0.000574	CcSEcCtD
Celecoxib—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000108	0.000571	CcSEcCtD
Celecoxib—Pharyngitis—Doxorubicin—thyroid cancer	0.000108	0.00057	CcSEcCtD
Celecoxib—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000107	0.000567	CcSEcCtD
Celecoxib—Oedema peripheral—Doxorubicin—thyroid cancer	0.000107	0.000565	CcSEcCtD
Celecoxib—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000107	0.000564	CcSEcCtD
Celecoxib—Angiopathy—Epirubicin—thyroid cancer	0.000107	0.000563	CcSEcCtD
Celecoxib—Urethral disorder—Doxorubicin—thyroid cancer	0.000107	0.000563	CcSEcCtD
Celecoxib—Immune system disorder—Epirubicin—thyroid cancer	0.000106	0.00056	CcSEcCtD
Celecoxib—Mediastinal disorder—Epirubicin—thyroid cancer	0.000106	0.000559	CcSEcCtD
Celecoxib—Arrhythmia—Epirubicin—thyroid cancer	0.000105	0.000554	CcSEcCtD
Celecoxib—Alopecia—Epirubicin—thyroid cancer	0.000104	0.000548	CcSEcCtD
Celecoxib—Mental disorder—Epirubicin—thyroid cancer	0.000103	0.000543	CcSEcCtD
Celecoxib—Erythema multiforme—Doxorubicin—thyroid cancer	0.000103	0.000543	CcSEcCtD
Celecoxib—Eye disorder—Doxorubicin—thyroid cancer	0.000102	0.000536	CcSEcCtD
Celecoxib—Tinnitus—Doxorubicin—thyroid cancer	0.000101	0.000535	CcSEcCtD
Celecoxib—Flushing—Doxorubicin—thyroid cancer	0.000101	0.000533	CcSEcCtD
Celecoxib—Cardiac disorder—Doxorubicin—thyroid cancer	0.000101	0.000533	CcSEcCtD
Celecoxib—Flatulence—Epirubicin—thyroid cancer	0.000101	0.000532	CcSEcCtD
Celecoxib—Tension—Epirubicin—thyroid cancer	0.0001	0.00053	CcSEcCtD
Celecoxib—Dysgeusia—Epirubicin—thyroid cancer	0.0001	0.000529	CcSEcCtD
Celecoxib—Nervousness—Epirubicin—thyroid cancer	9.95e-05	0.000524	CcSEcCtD
Celecoxib—Back pain—Epirubicin—thyroid cancer	9.9e-05	0.000522	CcSEcCtD
Celecoxib—Angiopathy—Doxorubicin—thyroid cancer	9.87e-05	0.000521	CcSEcCtD
Celecoxib—Muscle spasms—Epirubicin—thyroid cancer	9.84e-05	0.000519	CcSEcCtD
Celecoxib—Immune system disorder—Doxorubicin—thyroid cancer	9.83e-05	0.000518	CcSEcCtD
Celecoxib—Mediastinal disorder—Doxorubicin—thyroid cancer	9.81e-05	0.000517	CcSEcCtD
Celecoxib—Arrhythmia—Doxorubicin—thyroid cancer	9.72e-05	0.000513	CcSEcCtD
Celecoxib—Vision blurred—Epirubicin—thyroid cancer	9.65e-05	0.000509	CcSEcCtD
Celecoxib—Alopecia—Doxorubicin—thyroid cancer	9.62e-05	0.000507	CcSEcCtD
Celecoxib—Mental disorder—Doxorubicin—thyroid cancer	9.54e-05	0.000503	CcSEcCtD
Celecoxib—Anaemia—Epirubicin—thyroid cancer	9.46e-05	0.000499	CcSEcCtD
Celecoxib—Flatulence—Doxorubicin—thyroid cancer	9.34e-05	0.000492	CcSEcCtD
Celecoxib—Tension—Doxorubicin—thyroid cancer	9.3e-05	0.00049	CcSEcCtD
Celecoxib—Dysgeusia—Doxorubicin—thyroid cancer	9.28e-05	0.000489	CcSEcCtD
Celecoxib—Nervousness—Doxorubicin—thyroid cancer	9.2e-05	0.000485	CcSEcCtD
Celecoxib—Vertigo—Epirubicin—thyroid cancer	9.2e-05	0.000485	CcSEcCtD
Celecoxib—Syncope—Epirubicin—thyroid cancer	9.18e-05	0.000484	CcSEcCtD
Celecoxib—Leukopenia—Epirubicin—thyroid cancer	9.17e-05	0.000483	CcSEcCtD
Celecoxib—Back pain—Doxorubicin—thyroid cancer	9.16e-05	0.000483	CcSEcCtD
Celecoxib—Muscle spasms—Doxorubicin—thyroid cancer	9.11e-05	0.00048	CcSEcCtD
Celecoxib—Palpitations—Epirubicin—thyroid cancer	9.05e-05	0.000477	CcSEcCtD
Celecoxib—Loss of consciousness—Epirubicin—thyroid cancer	9e-05	0.000475	CcSEcCtD
Celecoxib—Cough—Epirubicin—thyroid cancer	8.94e-05	0.000471	CcSEcCtD
Celecoxib—Vision blurred—Doxorubicin—thyroid cancer	8.93e-05	0.000471	CcSEcCtD
Celecoxib—Hypertension—Epirubicin—thyroid cancer	8.84e-05	0.000466	CcSEcCtD
Celecoxib—Anaemia—Doxorubicin—thyroid cancer	8.76e-05	0.000462	CcSEcCtD
Celecoxib—Myalgia—Epirubicin—thyroid cancer	8.72e-05	0.00046	CcSEcCtD
Celecoxib—Arthralgia—Epirubicin—thyroid cancer	8.72e-05	0.00046	CcSEcCtD
Celecoxib—Chest pain—Epirubicin—thyroid cancer	8.72e-05	0.00046	CcSEcCtD
Celecoxib—Anxiety—Epirubicin—thyroid cancer	8.69e-05	0.000458	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	8.66e-05	0.000457	CcSEcCtD
Celecoxib—Dry mouth—Epirubicin—thyroid cancer	8.53e-05	0.00045	CcSEcCtD
Celecoxib—Vertigo—Doxorubicin—thyroid cancer	8.51e-05	0.000449	CcSEcCtD
Celecoxib—Syncope—Doxorubicin—thyroid cancer	8.5e-05	0.000448	CcSEcCtD
Celecoxib—Leukopenia—Doxorubicin—thyroid cancer	8.48e-05	0.000447	CcSEcCtD
Celecoxib—Confusional state—Epirubicin—thyroid cancer	8.43e-05	0.000444	CcSEcCtD
Celecoxib—Palpitations—Doxorubicin—thyroid cancer	8.37e-05	0.000442	CcSEcCtD
Celecoxib—Oedema—Epirubicin—thyroid cancer	8.36e-05	0.000441	CcSEcCtD
Celecoxib—Anaphylactic shock—Epirubicin—thyroid cancer	8.36e-05	0.000441	CcSEcCtD
Celecoxib—Loss of consciousness—Doxorubicin—thyroid cancer	8.33e-05	0.000439	CcSEcCtD
Celecoxib—Infection—Epirubicin—thyroid cancer	8.3e-05	0.000438	CcSEcCtD
Celecoxib—Cough—Doxorubicin—thyroid cancer	8.27e-05	0.000436	CcSEcCtD
Celecoxib—Shock—Epirubicin—thyroid cancer	8.22e-05	0.000434	CcSEcCtD
Celecoxib—Nervous system disorder—Epirubicin—thyroid cancer	8.2e-05	0.000432	CcSEcCtD
Celecoxib—Thrombocytopenia—Epirubicin—thyroid cancer	8.18e-05	0.000432	CcSEcCtD
Celecoxib—Hypertension—Doxorubicin—thyroid cancer	8.18e-05	0.000431	CcSEcCtD
Celecoxib—Tachycardia—Epirubicin—thyroid cancer	8.16e-05	0.00043	CcSEcCtD
Celecoxib—Skin disorder—Epirubicin—thyroid cancer	8.12e-05	0.000428	CcSEcCtD
Celecoxib—Hyperhidrosis—Epirubicin—thyroid cancer	8.08e-05	0.000426	CcSEcCtD
Celecoxib—Arthralgia—Doxorubicin—thyroid cancer	8.07e-05	0.000425	CcSEcCtD
Celecoxib—Chest pain—Doxorubicin—thyroid cancer	8.07e-05	0.000425	CcSEcCtD
Celecoxib—Myalgia—Doxorubicin—thyroid cancer	8.07e-05	0.000425	CcSEcCtD
Celecoxib—Anxiety—Doxorubicin—thyroid cancer	8.04e-05	0.000424	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	8.01e-05	0.000422	CcSEcCtD
Celecoxib—Anorexia—Epirubicin—thyroid cancer	7.97e-05	0.00042	CcSEcCtD
Celecoxib—Dry mouth—Doxorubicin—thyroid cancer	7.89e-05	0.000416	CcSEcCtD
Celecoxib—Confusional state—Doxorubicin—thyroid cancer	7.8e-05	0.000411	CcSEcCtD
Celecoxib—Anaphylactic shock—Doxorubicin—thyroid cancer	7.73e-05	0.000408	CcSEcCtD
Celecoxib—Oedema—Doxorubicin—thyroid cancer	7.73e-05	0.000408	CcSEcCtD
Celecoxib—Infection—Doxorubicin—thyroid cancer	7.68e-05	0.000405	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Epirubicin—thyroid cancer	7.61e-05	0.000402	CcSEcCtD
Celecoxib—Shock—Doxorubicin—thyroid cancer	7.61e-05	0.000401	CcSEcCtD
Celecoxib—Nervous system disorder—Doxorubicin—thyroid cancer	7.58e-05	0.0004	CcSEcCtD
Celecoxib—Thrombocytopenia—Doxorubicin—thyroid cancer	7.57e-05	0.000399	CcSEcCtD
Celecoxib—Insomnia—Epirubicin—thyroid cancer	7.56e-05	0.000399	CcSEcCtD
Celecoxib—Tachycardia—Doxorubicin—thyroid cancer	7.55e-05	0.000398	CcSEcCtD
Celecoxib—Skin disorder—Doxorubicin—thyroid cancer	7.51e-05	0.000396	CcSEcCtD
Celecoxib—Paraesthesia—Epirubicin—thyroid cancer	7.5e-05	0.000396	CcSEcCtD
Celecoxib—Hyperhidrosis—Doxorubicin—thyroid cancer	7.48e-05	0.000394	CcSEcCtD
Celecoxib—Dyspnoea—Epirubicin—thyroid cancer	7.45e-05	0.000393	CcSEcCtD
Celecoxib—Somnolence—Epirubicin—thyroid cancer	7.43e-05	0.000392	CcSEcCtD
Celecoxib—Anorexia—Doxorubicin—thyroid cancer	7.37e-05	0.000389	CcSEcCtD
Celecoxib—Dyspepsia—Epirubicin—thyroid cancer	7.36e-05	0.000388	CcSEcCtD
Celecoxib—Decreased appetite—Epirubicin—thyroid cancer	7.26e-05	0.000383	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Epirubicin—thyroid cancer	7.21e-05	0.00038	CcSEcCtD
Celecoxib—Fatigue—Epirubicin—thyroid cancer	7.2e-05	0.00038	CcSEcCtD
Celecoxib—Constipation—Epirubicin—thyroid cancer	7.15e-05	0.000377	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	7.04e-05	0.000372	CcSEcCtD
Celecoxib—Insomnia—Doxorubicin—thyroid cancer	6.99e-05	0.000369	CcSEcCtD
Celecoxib—Paraesthesia—Doxorubicin—thyroid cancer	6.94e-05	0.000366	CcSEcCtD
Celecoxib—Dyspnoea—Doxorubicin—thyroid cancer	6.89e-05	0.000364	CcSEcCtD
Celecoxib—Feeling abnormal—Epirubicin—thyroid cancer	6.89e-05	0.000363	CcSEcCtD
Celecoxib—Somnolence—Doxorubicin—thyroid cancer	6.87e-05	0.000363	CcSEcCtD
Celecoxib—Gastrointestinal pain—Epirubicin—thyroid cancer	6.83e-05	0.00036	CcSEcCtD
Celecoxib—Dyspepsia—Doxorubicin—thyroid cancer	6.81e-05	0.000359	CcSEcCtD
Celecoxib—Decreased appetite—Doxorubicin—thyroid cancer	6.72e-05	0.000354	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Doxorubicin—thyroid cancer	6.68e-05	0.000352	CcSEcCtD
Celecoxib—Fatigue—Doxorubicin—thyroid cancer	6.67e-05	0.000352	CcSEcCtD
Celecoxib—Urticaria—Epirubicin—thyroid cancer	6.64e-05	0.00035	CcSEcCtD
Celecoxib—Constipation—Doxorubicin—thyroid cancer	6.61e-05	0.000349	CcSEcCtD
Celecoxib—Body temperature increased—Epirubicin—thyroid cancer	6.61e-05	0.000348	CcSEcCtD
Celecoxib—Abdominal pain—Epirubicin—thyroid cancer	6.61e-05	0.000348	CcSEcCtD
Celecoxib—Feeling abnormal—Doxorubicin—thyroid cancer	6.37e-05	0.000336	CcSEcCtD
Celecoxib—Gastrointestinal pain—Doxorubicin—thyroid cancer	6.32e-05	0.000333	CcSEcCtD
Celecoxib—Hypersensitivity—Epirubicin—thyroid cancer	6.16e-05	0.000325	CcSEcCtD
Celecoxib—Urticaria—Doxorubicin—thyroid cancer	6.14e-05	0.000324	CcSEcCtD
Celecoxib—Abdominal pain—Doxorubicin—thyroid cancer	6.11e-05	0.000322	CcSEcCtD
Celecoxib—Body temperature increased—Doxorubicin—thyroid cancer	6.11e-05	0.000322	CcSEcCtD
Celecoxib—Asthenia—Epirubicin—thyroid cancer	6e-05	0.000316	CcSEcCtD
Celecoxib—Pruritus—Epirubicin—thyroid cancer	5.91e-05	0.000312	CcSEcCtD
Celecoxib—Diarrhoea—Epirubicin—thyroid cancer	5.72e-05	0.000302	CcSEcCtD
Celecoxib—Hypersensitivity—Doxorubicin—thyroid cancer	5.7e-05	0.0003	CcSEcCtD
Celecoxib—Asthenia—Doxorubicin—thyroid cancer	5.55e-05	0.000293	CcSEcCtD
Celecoxib—Dizziness—Epirubicin—thyroid cancer	5.53e-05	0.000291	CcSEcCtD
Celecoxib—Pruritus—Doxorubicin—thyroid cancer	5.47e-05	0.000289	CcSEcCtD
Celecoxib—Vomiting—Epirubicin—thyroid cancer	5.31e-05	0.00028	CcSEcCtD
Celecoxib—Diarrhoea—Doxorubicin—thyroid cancer	5.29e-05	0.000279	CcSEcCtD
Celecoxib—Rash—Epirubicin—thyroid cancer	5.27e-05	0.000278	CcSEcCtD
Celecoxib—Dermatitis—Epirubicin—thyroid cancer	5.26e-05	0.000278	CcSEcCtD
Celecoxib—Headache—Epirubicin—thyroid cancer	5.24e-05	0.000276	CcSEcCtD
Celecoxib—Dizziness—Doxorubicin—thyroid cancer	5.11e-05	0.00027	CcSEcCtD
Celecoxib—Nausea—Epirubicin—thyroid cancer	4.96e-05	0.000262	CcSEcCtD
Celecoxib—Vomiting—Doxorubicin—thyroid cancer	4.92e-05	0.000259	CcSEcCtD
Celecoxib—Rash—Doxorubicin—thyroid cancer	4.88e-05	0.000257	CcSEcCtD
Celecoxib—Dermatitis—Doxorubicin—thyroid cancer	4.87e-05	0.000257	CcSEcCtD
Celecoxib—Headache—Doxorubicin—thyroid cancer	4.84e-05	0.000255	CcSEcCtD
Celecoxib—Nausea—Doxorubicin—thyroid cancer	4.59e-05	0.000242	CcSEcCtD
Celecoxib—PDPK1—Hemostasis—NRAS—thyroid cancer	3.61e-05	0.000282	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—MINPP1—thyroid cancer	3.61e-05	0.000281	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—MINPP1—thyroid cancer	3.58e-05	0.000279	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TCF7L1—thyroid cancer	3.58e-05	0.000279	CbGpPWpGaD
Celecoxib—MAPK14—TGF-beta Signaling Pathway—AKT1—thyroid cancer	3.56e-05	0.000277	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	3.52e-05	0.000275	CbGpPWpGaD
Celecoxib—PDPK1—Disease—TERT—thyroid cancer	3.52e-05	0.000274	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—PTEN—thyroid cancer	3.5e-05	0.000273	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CHST14—thyroid cancer	3.5e-05	0.000273	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—HPGD—thyroid cancer	3.49e-05	0.000272	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—TP53—thyroid cancer	3.47e-05	0.00027	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—CP—thyroid cancer	3.46e-05	0.000269	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—TPR—thyroid cancer	3.46e-05	0.000269	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—PPARG—thyroid cancer	3.45e-05	0.000269	CbGpPWpGaD
Celecoxib—MAPK14—Insulin Signaling—HRAS—thyroid cancer	3.45e-05	0.000269	CbGpPWpGaD
Celecoxib—MAPK14—EGF/EGFR Signaling Pathway—HRAS—thyroid cancer	3.42e-05	0.000266	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CDK1—thyroid cancer	3.42e-05	0.000266	CbGpPWpGaD
Celecoxib—MAPK14—Regulation of toll-like receptor signaling pathway—AKT1—thyroid cancer	3.41e-05	0.000266	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	3.4e-05	0.000265	CbGpPWpGaD
Celecoxib—PDPK1—Disease—HIF1A—thyroid cancer	3.36e-05	0.000262	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—PTEN—thyroid cancer	3.32e-05	0.000259	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—KRAS—thyroid cancer	3.32e-05	0.000258	CbGpPWpGaD
Celecoxib—MAPK14—BDNF signaling pathway—AKT1—thyroid cancer	3.32e-05	0.000258	CbGpPWpGaD
Celecoxib—CA9—Metabolism—RXRA—thyroid cancer	3.27e-05	0.000254	CbGpPWpGaD
Celecoxib—PTGS2—Disease—TCF7L1—thyroid cancer	3.27e-05	0.000254	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—NRAS—thyroid cancer	3.25e-05	0.000254	CbGpPWpGaD
Celecoxib—CYP3A4—Biological oxidations—RXRA—thyroid cancer	3.22e-05	0.00025	CbGpPWpGaD
Celecoxib—CA12—Metabolism—PPARG—thyroid cancer	3.2e-05	0.000249	CbGpPWpGaD
Celecoxib—MAPK14—Cellular Senescence—TP53—thyroid cancer	3.2e-05	0.000249	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	3.13e-05	0.000244	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—PPARG—thyroid cancer	3.13e-05	0.000244	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—NRAS—thyroid cancer	3.13e-05	0.000243	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—KRAS—thyroid cancer	3.11e-05	0.000242	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—NDUFA13—thyroid cancer	3.07e-05	0.000239	CbGpPWpGaD
Celecoxib—MAPK14—Insulin Signaling—AKT1—thyroid cancer	3.05e-05	0.000237	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—NDUFA13—thyroid cancer	3.05e-05	0.000237	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	3.04e-05	0.000237	CbGpPWpGaD
Celecoxib—MAPK14—EGF/EGFR Signaling Pathway—AKT1—thyroid cancer	3.02e-05	0.000235	CbGpPWpGaD
Celecoxib—CA14—Metabolism—PTGS2—thyroid cancer	2.99e-05	0.000233	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—NRAS—thyroid cancer	2.97e-05	0.000231	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—TP53—thyroid cancer	2.94e-05	0.000229	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	2.93e-05	0.000228	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—AKT1—thyroid cancer	2.93e-05	0.000228	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—PTGS2—thyroid cancer	2.91e-05	0.000227	CbGpPWpGaD
Celecoxib—CA6—Metabolism—PTGS2—thyroid cancer	2.91e-05	0.000227	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CHST14—thyroid cancer	2.89e-05	0.000225	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CHST14—thyroid cancer	2.86e-05	0.000223	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.83e-05	0.00022	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—HRAS—thyroid cancer	2.82e-05	0.00022	CbGpPWpGaD
Celecoxib—ALB—Metabolism—HPGD—thyroid cancer	2.82e-05	0.00022	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—KRAS—thyroid cancer	2.8e-05	0.000218	CbGpPWpGaD
Celecoxib—PDPK1—Disease—BRAF—thyroid cancer	2.78e-05	0.000217	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—TP53—thyroid cancer	2.77e-05	0.000215	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CDK1—thyroid cancer	2.75e-05	0.000214	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—NRG1—thyroid cancer	2.74e-05	0.000214	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—PTGS2—thyroid cancer	2.72e-05	0.000212	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—KRAS—thyroid cancer	2.69e-05	0.00021	CbGpPWpGaD
Celecoxib—ABCC4—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	2.69e-05	0.000209	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	2.65e-05	0.000206	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—HRAS—thyroid cancer	2.64e-05	0.000206	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IFNA2—thyroid cancer	2.64e-05	0.000206	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TSHR—thyroid cancer	2.62e-05	0.000204	CbGpPWpGaD
Celecoxib—CA14—Metabolism—PTEN—thyroid cancer	2.61e-05	0.000203	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—IFNA2—thyroid cancer	2.6e-05	0.000203	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2.59e-05	0.000202	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PRKAR1A—thyroid cancer	2.58e-05	0.000201	CbGpPWpGaD
Celecoxib—CA4—Metabolism—PPARG—thyroid cancer	2.55e-05	0.000199	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—KRAS—thyroid cancer	2.55e-05	0.000199	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—PTEN—thyroid cancer	2.54e-05	0.000198	CbGpPWpGaD
Celecoxib—CA6—Metabolism—PTEN—thyroid cancer	2.54e-05	0.000198	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—RXRA—thyroid cancer	2.53e-05	0.000197	CbGpPWpGaD
Celecoxib—CA12—Metabolism—PTGS2—thyroid cancer	2.52e-05	0.000196	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—AKT1—thyroid cancer	2.49e-05	0.000194	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MEN1—thyroid cancer	2.46e-05	0.000192	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TERT—thyroid cancer	2.46e-05	0.000192	CbGpPWpGaD
Celecoxib—CA2—Metabolism—PPARG—thyroid cancer	2.45e-05	0.000191	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—TP53—thyroid cancer	2.42e-05	0.000188	CbGpPWpGaD
Celecoxib—PTGS2—Disease—TPR—thyroid cancer	2.39e-05	0.000186	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—HRAS—thyroid cancer	2.38e-05	0.000185	CbGpPWpGaD
Celecoxib—MAPK14—Metabolism of mRNA—AKT1—thyroid cancer	2.37e-05	0.000185	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—PTEN—thyroid cancer	2.37e-05	0.000185	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—MINPP1—thyroid cancer	2.36e-05	0.000184	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—HIF1A—thyroid cancer	2.35e-05	0.000183	CbGpPWpGaD
Celecoxib—MAPK14—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	2.35e-05	0.000183	CbGpPWpGaD
Celecoxib—PTGS2—Disease—PRKAR1A—thyroid cancer	2.35e-05	0.000183	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—AKT1—thyroid cancer	2.34e-05	0.000182	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—HPGD—thyroid cancer	2.33e-05	0.000181	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—HPGD—thyroid cancer	2.31e-05	0.00018	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.29e-05	0.000178	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—HRAS—thyroid cancer	2.29e-05	0.000178	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	2.25e-05	0.000175	CbGpPWpGaD
Celecoxib—PDPK1—Disease—PTGS2—thyroid cancer	2.25e-05	0.000175	CbGpPWpGaD
Celecoxib—PTGS2—Disease—MEN1—thyroid cancer	2.25e-05	0.000175	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PTCH1—thyroid cancer	2.23e-05	0.000174	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—NRG1—thyroid cancer	2.2e-05	0.000172	CbGpPWpGaD
Celecoxib—CA12—Metabolism—PTEN—thyroid cancer	2.2e-05	0.000171	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.17e-05	0.000169	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—HRAS—thyroid cancer	2.17e-05	0.000169	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—NRAS—thyroid cancer	2.15e-05	0.000167	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—PTEN—thyroid cancer	2.12e-05	0.000166	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—AKT1—thyroid cancer	2.1e-05	0.000164	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—NRAS—thyroid cancer	2.07e-05	0.000162	CbGpPWpGaD
Celecoxib—CA9—Metabolism—PPARG—thyroid cancer	2.06e-05	0.000161	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SST—thyroid cancer	2.04e-05	0.000159	CbGpPWpGaD
Celecoxib—MAPK14—Metabolism of RNA—AKT1—thyroid cancer	2.03e-05	0.000158	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—AKT1—thyroid cancer	2.02e-05	0.000157	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—NDUFA13—thyroid cancer	2.01e-05	0.000156	CbGpPWpGaD
Celecoxib—CA4—Metabolism—PTGS2—thyroid cancer	2.01e-05	0.000156	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—TPR—thyroid cancer	2e-05	0.000156	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	2e-05	0.000156	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PRKAR1A—thyroid cancer	1.97e-05	0.000153	CbGpPWpGaD
Celecoxib—PDPK1—Disease—PTEN—thyroid cancer	1.96e-05	0.000153	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CALCA—thyroid cancer	1.96e-05	0.000153	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—BRAF—thyroid cancer	1.95e-05	0.000152	CbGpPWpGaD
Celecoxib—CA2—Metabolism—PTGS2—thyroid cancer	1.92e-05	0.00015	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—AKT1—thyroid cancer	1.92e-05	0.000149	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—NRAS—thyroid cancer	1.91e-05	0.000149	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—PTEN—thyroid cancer	1.9e-05	0.000148	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—NRAS—thyroid cancer	1.9e-05	0.000148	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CHST14—thyroid cancer	1.89e-05	0.000147	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—NRAS—thyroid cancer	1.88e-05	0.000146	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.87e-05	0.000146	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—KRAS—thyroid cancer	1.85e-05	0.000144	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CALCA—thyroid cancer	1.79e-05	0.000139	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—KRAS—thyroid cancer	1.79e-05	0.000139	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.78e-05	0.000139	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CDK1—thyroid cancer	1.78e-05	0.000138	CbGpPWpGaD
Celecoxib—CA4—Metabolism—PTEN—thyroid cancer	1.75e-05	0.000136	CbGpPWpGaD
Celecoxib—PDPK1—Disease—NRAS—thyroid cancer	1.75e-05	0.000136	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—NRAS—thyroid cancer	1.69e-05	0.000132	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	1.69e-05	0.000132	CbGpPWpGaD
Celecoxib—CA2—Metabolism—PTEN—thyroid cancer	1.68e-05	0.000131	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—KRAS—thyroid cancer	1.65e-05	0.000128	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—TP53—thyroid cancer	1.64e-05	0.000128	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—KRAS—thyroid cancer	1.63e-05	0.000127	CbGpPWpGaD
Celecoxib—CA9—Metabolism—PTGS2—thyroid cancer	1.62e-05	0.000126	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CDK1—thyroid cancer	1.62e-05	0.000126	CbGpPWpGaD
Celecoxib—ALB—Metabolism—TPR—thyroid cancer	1.62e-05	0.000126	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—KRAS—thyroid cancer	1.62e-05	0.000126	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—PPARG—thyroid cancer	1.6e-05	0.000125	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PRKAR1A—thyroid cancer	1.59e-05	0.000124	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—HRAS—thyroid cancer	1.57e-05	0.000122	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—HPGD—thyroid cancer	1.52e-05	0.000119	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—HRAS—thyroid cancer	1.52e-05	0.000118	CbGpPWpGaD
Celecoxib—PDPK1—Disease—KRAS—thyroid cancer	1.51e-05	0.000117	CbGpPWpGaD
Celecoxib—CA14—Metabolism—AKT1—thyroid cancer	1.5e-05	0.000117	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—SLC5A5—thyroid cancer	1.5e-05	0.000117	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—AKT1—thyroid cancer	1.48e-05	0.000115	CbGpPWpGaD
Celecoxib—CA6—Metabolism—AKT1—thyroid cancer	1.46e-05	0.000114	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—AKT1—thyroid cancer	1.46e-05	0.000114	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—KRAS—thyroid cancer	1.46e-05	0.000113	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.44e-05	0.000113	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—TP53—thyroid cancer	1.44e-05	0.000112	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NRG1—thyroid cancer	1.43e-05	0.000111	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CCND1—thyroid cancer	1.42e-05	0.000111	CbGpPWpGaD
Celecoxib—CA9—Metabolism—PTEN—thyroid cancer	1.41e-05	0.00011	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—HRAS—thyroid cancer	1.4e-05	0.000109	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—HRAS—thyroid cancer	1.39e-05	0.000108	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—AKT1—thyroid cancer	1.39e-05	0.000108	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—HRAS—thyroid cancer	1.37e-05	0.000107	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—PTEN—thyroid cancer	1.37e-05	0.000107	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—AKT1—thyroid cancer	1.37e-05	0.000106	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—AKT1—thyroid cancer	1.34e-05	0.000104	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—TPR—thyroid cancer	1.34e-05	0.000104	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—TPR—thyroid cancer	1.33e-05	0.000103	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	1.32e-05	0.000102	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	1.3e-05	0.000102	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NRG1—thyroid cancer	1.3e-05	0.000101	CbGpPWpGaD
Celecoxib—PDPK1—Disease—HRAS—thyroid cancer	1.28e-05	9.97e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TERT—thyroid cancer	1.28e-05	9.97e-05	CbGpPWpGaD
Celecoxib—CA12—Metabolism—AKT1—thyroid cancer	1.27e-05	9.86e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—RXRA—thyroid cancer	1.26e-05	9.81e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—HRAS—thyroid cancer	1.24e-05	9.64e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—AKT1—thyroid cancer	1.24e-05	9.64e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—NRAS—thyroid cancer	1.23e-05	9.55e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.22e-05	9.54e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—AKT1—thyroid cancer	1.22e-05	9.54e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—HIF1A—thyroid cancer	1.22e-05	9.53e-05	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	1.22e-05	9.48e-05	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—AKT1—thyroid cancer	1.21e-05	9.45e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—SLC5A5—thyroid cancer	1.21e-05	9.45e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.18e-05	9.21e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—TERT—thyroid cancer	1.17e-05	9.09e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.14e-05	8.85e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—AKT1—thyroid cancer	1.13e-05	8.81e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—HIF1A—thyroid cancer	1.12e-05	8.7e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—PTEN—thyroid cancer	1.1e-05	8.6e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—AKT1—thyroid cancer	1.09e-05	8.51e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—KRAS—thyroid cancer	1.05e-05	8.22e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—RXRA—thyroid cancer	1.02e-05	7.94e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—BRAF—thyroid cancer	1.01e-05	7.89e-05	CbGpPWpGaD
Celecoxib—CA4—Metabolism—AKT1—thyroid cancer	1.01e-05	7.86e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—SLC5A5—thyroid cancer	1e-05	7.8e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—SLC5A5—thyroid cancer	9.92e-06	7.73e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	9.91e-06	7.72e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—NRAS—thyroid cancer	9.85e-06	7.67e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—NRAS—thyroid cancer	9.71e-06	7.56e-05	CbGpPWpGaD
Celecoxib—CA2—Metabolism—AKT1—thyroid cancer	9.67e-06	7.54e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TP53—thyroid cancer	9.37e-06	7.3e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	9.3e-06	7.24e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—BRAF—thyroid cancer	9.24e-06	7.2e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—HRAS—thyroid cancer	8.97e-06	6.98e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—TPR—thyroid cancer	8.74e-06	6.81e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	8.6e-06	6.7e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—KRAS—thyroid cancer	8.48e-06	6.6e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—RXRA—thyroid cancer	8.41e-06	6.55e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—KRAS—thyroid cancer	8.36e-06	6.51e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—RXRA—thyroid cancer	8.34e-06	6.5e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—AKT1—thyroid cancer	8.15e-06	6.35e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	8.11e-06	6.32e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PPARG—thyroid cancer	7.95e-06	6.19e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—AKT1—thyroid cancer	7.92e-06	6.17e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TP53—thyroid cancer	7.43e-06	5.79e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CCND1—thyroid cancer	7.4e-06	5.76e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HRAS—thyroid cancer	7.21e-06	5.61e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PTEN—thyroid cancer	7.14e-06	5.56e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—HRAS—thyroid cancer	7.1e-06	5.53e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SLC5A5—thyroid cancer	6.54e-06	5.1e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—PTEN—thyroid cancer	6.51e-06	5.07e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PPARG—thyroid cancer	6.43e-06	5.01e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NRAS—thyroid cancer	6.37e-06	4.96e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—AKT1—thyroid cancer	6.36e-06	4.96e-05	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—AKT1—thyroid cancer	6.33e-06	4.93e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—AKT1—thyroid cancer	6.27e-06	4.89e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NRAS—thyroid cancer	5.81e-06	4.53e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—RXRA—thyroid cancer	5.5e-06	4.28e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—KRAS—thyroid cancer	5.48e-06	4.27e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PTEN—thyroid cancer	5.45e-06	4.25e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PPARG—thyroid cancer	5.31e-06	4.14e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PPARG—thyroid cancer	5.26e-06	4.1e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PTGS2—thyroid cancer	5.06e-06	3.94e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—KRAS—thyroid cancer	5e-06	3.9e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TP53—thyroid cancer	4.87e-06	3.8e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—HRAS—thyroid cancer	4.66e-06	3.63e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PTEN—thyroid cancer	4.41e-06	3.44e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—HRAS—thyroid cancer	4.25e-06	3.31e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PTGS2—thyroid cancer	4.18e-06	3.25e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PTGS2—thyroid cancer	4.14e-06	3.23e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—AKT1—thyroid cancer	4.11e-06	3.2e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—AKT1—thyroid cancer	3.75e-06	2.92e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PTEN—thyroid cancer	3.64e-06	2.84e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PTEN—thyroid cancer	3.61e-06	2.81e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PPARG—thyroid cancer	3.47e-06	2.7e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—AKT1—thyroid cancer	3.14e-06	2.45e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PTGS2—thyroid cancer	2.73e-06	2.13e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—AKT1—thyroid cancer	2.54e-06	1.98e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PTEN—thyroid cancer	2.38e-06	1.86e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—AKT1—thyroid cancer	2.1e-06	1.64e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—AKT1—thyroid cancer	2.08e-06	1.62e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—AKT1—thyroid cancer	1.37e-06	1.07e-05	CbGpPWpGaD
